[HTML][HTML] Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

…, J Farrar, D Crook, D Cook, E Rourke, R Studley… - Nature medicine, 2021 - nature.com
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re-evaluation, …

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom

…, J Farrar, I Diamond, E Rourke, R Studley… - Nature medicine, 2021 - nature.com
The effectiveness of COVID-19 vaccination in preventing new severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infections in the general community is still unclear. Here, …

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

…, PC Matthews, D Ayoubkhani, R Studley… - Nature …, 2021 - nature.com
We report that in a cohort of 45,965 adults, who were receiving either the ChAdOx1 or the
BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2, …

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

…, D Reeve, P Shah, R Snook, R Studley… - The Lancet Public …, 2021 - thelancet.com
Background Decisions about the continued need for control measures to contain the spread
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rely on accurate and up-…

Omicron-associated changes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) symptoms in the United Kingdom

…, E Pritchard, T House, R Studley… - Clinical Infectious …, 2023 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta
variant has been replaced by the highly transmissible Omicron BA.1 variant, and subsequently …

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

…, N Stoesser, PC Matthews, I Diamond, R Studley… - Nature Medicine, 2022 - nature.com
Antibody responses are an important part of immunity after Coronavirus Disease 2019 (COVID-19)
vaccination. However, antibody trajectories and the associated duration of protection …

Tracking the emergence of SARS-CoV-2 alpha variant in the United Kingdom

…, J Farrar, I Diamond, R Studley… - … England Journal of …, 2021 - Mass Medical Soc
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom | NEJM Skip to
main content NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare …

[HTML][HTML] Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

…, N Stoesser, T Maddox, L Lorenzi, R Studley… - Nature …, 2021 - nature.com
Understanding the trajectory, duration, and determinants of antibody responses after SARS-CoV-2
infection can inform subsequent protection and risk of reinfection, however large-…

Protection against SARS-CoV-2 Omicron BA. 4/5 variant following booster vaccination or breakthrough infection in the UK

…, N Stoesser, JN Newton, I Diamond, R Studley… - Nature …, 2023 - nature.com
Following primary SARS-CoV-2 vaccination, whether boosters or breakthrough infections
provide greater protection against SARS-CoV-2 infection is incompletely understood. Here we …

Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time

…, JI Bell, JN Newton, J Farrar, I Diamond, R Studley… - Elife, 2021 - elifesciences.org
Background: Information on SARS-CoV-2 in representative community surveillance is limited,
particularly cycle threshold (Ct) values (a proxy for viral load). Methods: We included all …